Clinical Trial Update: Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating the pharmacokinetics of intraperitoneal and intravenous meropenem, ampicillin, aztreonam, and ciprofloxacin in automated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Dialysis
• Peritoneal Dialysis-associated Peritonitis

Drugs mentioned

• AMPICILLIN (AMPICILLIN)
• Aztreonam (aztreonam)
• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Meropenem (Meropenem)

Snippet

Sponsor: Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | Conditions: Peritoneal Dialysis-associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2, Phase 3 | Status: COMPLETED